Showing items 1–100
Transcription activator-like effector (tale) - lysine-specific demethylase 1 (LSD1…
Grant US-11891631-B2
United States of America
T cell-antigen coupler with various construct optimizations
Grant US-11878035-B2
United States of America
Di-sulfide containing cell penetrating peptides and methods of making and using thereof
Grant US-11878046-B2
United States of America
Bicyclic peptidyl inhibitor of tumor necrosis factor-alpha
Grant US-11859019-B2
United States of America
18F labeling of proteins using sortases
Grant US-11850216-B2
United States of America
Dosing regimens and related compositions and methods
Grant US-11844841-B2
United States of America
RNA formulations
Grant US-11786607-B2
United States of America
Polynucleotides encoding optimized engineered meganucleases having specificity for a…
Grant US-11788077-B2
United States of America
Optimized engineered nucleases having specificity for the human T cell receptor alpha…
Grant US-11786554-B2
United States of America
Methods of making lipid nanoparticles
Grant US-11744801-B2
United States of America
Respiratory syncytial virus (RSV) vaccine
Grant US-11739125-B2
United States of America
Peptides and nanoparticles for intracellular delivery of molecules
Grant US-11713336-B2
United States of America
Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one…
Grant US-11690910-B2
United States of America
Vaccination in newborns and infants
Grant US-11672856-B2
United States of America
T cell-antigen coupler with Y182T mutation and methods and uses thereof
Grant US-11643472-B2
United States of America
Inhibition of TREM receptor signaling with peptide variants
Grant US-11638739-B2
United States of America
Glycan-interacting compounds and methods of use
Grant US-RE49435-E1
United States of America
Peptidyl inhibitors of calcineurin-NFAT interaction
Grant US-11576946-B2
United States of America
Methods of transcription activator like effector assembly
Grant US-11472849-B2
United States of America
BCMA T cell-antigen couplers and uses thereof
Grant US-11453723-B1
United States of America
Trifunctional T cell-antigen coupler and methods and uses thereof
Grant US-11421014-B2
United States of America
Cell-penetrating compstatin analogs and uses thereof
Grant US-11407789-B2
United States of America
T cell-antigen coupler with various construct optimizations
Grant US-11406667-B2
United States of America
Glycan-interacting compounds and methods of use
Grant US-11401330-B2
United States of America
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its…
Grant US-11369691-B2
United States of America
Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and…
Grant US-11352394-B2
United States of America
Di-sulfide containing cell penetrating peptides and methods of making and using thereof
Grant US-11351222-B2
United States of America
Fusion comprising a cell penetrating peptide, a multi epitope and a TLR peptide agonist…
Grant US-11338027-B2
United States of America
COMBINATION OF A STING AGONIST AND A COMPLEX COMPRISING A CELL PENETRATING PEPTIDE, A…
Application WO-2022079175-A1
World Intellectual Property Organisation (WIPO)
Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and…
Grant US-11292815-B2
United States of America
Engineered nucleases useful for treatment of hemophilia A
Grant US-11278632-B2
United States of America
Engineered meganucleases specific for recognition sequences in the Hepatitis B virus…
Grant US-11274285-B2
United States of America
Nucleic acids encoding engineered meganucleases with recognition sequences found in the…
Grant US-11266693-B2
United States of America
Genetically-modified cells comprising a modified human T cell receptor alpha constant…
Grant US-11268065-B2
United States of America
Glycan-interacting compounds and methods of use
Grant US-11253609-B2
United States of America
Cell penetrating peptides and methods of making and using thereof
Grant US-11225506-B2
United States of America
Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy
Grant US-11168310-B2
United States of America
Optimized engineered meganucleases having specificity for a recognition sequence in the…
Grant US-11142750-B2
United States of America
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its…
Grant US-11135312-B2
United States of America
Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant
Grant US-11110166-B2
United States of America
Genetically-modified T cells comprising a modified intron in the T cell receptor alpha…
Grant US-11053484-B2
United States of America
Dosing regimens and related compositions and methods
Grant US-11040107-B2
United States of America
Glycan-interacting compounds and methods of use
Grant US-11028181-B2
United States of America
MODIFIED T CELLS AND METHODS OF THEIR USE
Application US-20210137978-A1
United States of America
COMPOSITIONS AND METHODS FOR GROWTH FACTOR MODULATION
Application EP-3816625-A1
European Patent Office
Cell-penetrating compstatin analogs and uses thereof
Grant US-10941184-B2
United States of America
Topical delivery of therapeutic agents using cell-penetrating peptides for the treatment…
Grant US-10905770-B2
United States of America
Modified RNA with decreased immunostimulatory properties
Grant US-10898584-B2
United States of America
TAL-Tet1 fusion proteins and methods of use thereof
Grant US-10894950-B2
United States of America
CELL PENETRATING PEPTIDES FOR INTRACELLULAR DELIVERY OF MOLECULES
Application EP-3757114-A1
European Patent Office
Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and…
Grant US-10875893-B2
United States of America
Cell penetrating peptides and methods of making and using thereof
Grant US-10815276-B2
United States of America
Polynucleotides encoding immune modulating polypeptides
Grant US-10815291-B2
United States of America
Engineered meganucleases with recognition sequences found in the human T cell receptor…
Grant US-10799535-B2
United States of America
Engineered nucleic acids and methods of use thereof
Grant US-10751386-B2
United States of America
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic…
Grant US-10751424-B2
United States of America
A NOVEL COMPLEX COMPRISING A CELL PENETRATING PEPTIDE, A CARGO AND A TLR PEPTIDE AGONIST…
Application EP-3693009-A1
European Patent Office
Tale transcriptional activators
Grant US-10731167-B2
United States of America
Vaccination in newborns and infants
Grant US-10729761-B2
United States of America
Cell penetrating peptides for intracellular delivery of molecules
Grant US-10688194-B2
United States of America
Tale transcriptional activators
Grant US-10676749-B2
United States of America
Engineered meganucleases specific for recognition sequences in the hepatitis B virus…
Grant US-10662416-B2
United States of America
Cell penetrating peptides and methods of making and using thereof
Grant US-10626147-B2
United States of America
AN ENGINEERED MULTI-COMPONENT SYSTEM FOR IDENTIFICATION AND CHARACTERISATION OF T-CELL…
Application US-20200095574-A1
United States of America
Vaccination in newborns and infants
Grant US-10596252-B2
United States of America
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its…
Grant US-10568972-B2
United States of America
Vaccine composition comprising complexed immunostimulatory nucleic acids and antigens…
Grant US-10568958-B2
United States of America
PEPTIDES FOR USE AS CELL-PENETRATING PEPTIDES
Application WO-2020016242-A1
World Intellectual Property Organisation (WIPO)
PEPTIDES FOR USE AS CELL-PENETRATING PEPTIDES
Application EP-3597223-A1
European Patent Office
Peptidyl calcineurin inhibitors
Grant US-10456443-B2
United States of America
Cell penetrating peptides for intracellular delivery of molecules
Application US-10421784-B2
United States of America
Protein surface remodeling
Grant US-10407474-B2
United States of America
Methods of selecting compstatin mimetics
Grant US-10407466-B2
United States of America
Modulators of the SRC-kinase activity for preventing or treating metastatic cancer
Grant US-10400008-B2
United States of America
Peptide-mediated non-covalent delivery of active agents across the blood-brain barrier
Grant US-10377813-B2
United States of America
Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant
Grant US-10369216-B2
United States of America
Polynucleotides encoding low density lipoprotein receptor
Grant US-10323076-B2
United States of America
Cell-penetrating compstatin analogs and uses thereof
Grant US-10308687-B2
United States of America
Stablized EZH2 peptides
Grant US-10308926-B2
United States of America
Cell penetrating peptides for intracellular delivery of molecules
Application US-10287581-B2
United States of America
Methods of transcription activator like effector assembly
Grant US-10273271-B2
United States of America
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its…
Grant US-10188748-B2
United States of America
Cell penetrating peptides for intracellular delivery of molecules
Application US-10189876-B2
United States of America
Vaccination in newborns and infants
Grant US-10172935-B2
United States of America
Cell penetrating peptides for intracellular delivery of molecules
Grant US-10118944-B2
United States of America
Complexes of RNA and cationic peptides for transfection and for immunostimulation
Grant US-10111967-B2
United States of America
Cell penetrating peptides for intracellular delivery of molecules
Application US-10111965-B2
United States of America
Genetically-modified cells comprising a modified human T cell receptor alpha constant…
Grant US-10093900-B2
United States of America
Genetically-modified cells comprising a modified human T cell receptor alpha constant…
Grant US-10093899-B1
United States of America
Peptide-mediated delivery of immunoglobulins across the blood-brain barrier
Grant US-10072065-B2
United States of America
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
Grant US-10064959-B2
United States of America
Engineered nucleic acids and methods of use thereof
Grant US-10022425-B2
United States of America
Method of treating endometriosis
Grant US-10023612-B2
United States of America
Genetically-modified cells comprising a modified human T cell receptor alpha constant…
Grant US-9993501-B2
United States of America
Genetically-modified cells comprising a modified human T cell receptor alpha constant…
Grant US-9993502-B1
United States of America
Genetically-modified cells comprising a modified human T cell receptor alpha constant…
Grant US-9969975-B1
United States of America
Genetically-modified cells comprising a modified human T cell receptor alpha constant…
Grant US-9950010-B1
United States of America
Delivery and formulation of engineered nucleic acids
Grant US-9950068-B2
United States of America
Genetically-modified cells comprising a modified human T cell receptor alpha constant…
Grant US-9950011-B1
United States of America
Showing items 1–100